Albert Lai

机构：University of California, Los Angeles, UCLA Health, AbbVie (United States) · ORCID：0000-0002-7265-2986

发表论文 491 篇 · 总被引 18183 次 · h-index 74

代表论文

• Impact of corticosteroid administration on contrast-enhancing volume and diffusion MRI in treatment naïve glioblastoma (2025 · Neuro-Oncology · 被引 8)
• Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with In Vivo Target Engagement (2024 · Journal of Medicinal Chemistry · 被引 6)
• Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas (2024 · Neuroradiology · 被引 5)
• Modeling gliomas with organoids: Classification, fidelity, and guidelines for translational neuro-oncology (2026 · Neuro-Oncology · 被引 3)
• Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response (2025 · Journal of Neuro-Oncology · 被引 2)
• Perfusion, diffusion, and anatomical MRI characteristics of pathologically confirmed malignant transformation in IDH-mutant gliomas (2025 · Neuro-Oncology · 被引 1)